1
|
Rasaq Kayode O, Afeez Babatunde O. Cabenuva®: Differentiated service delivery and the community Pharmacists' roles in achieving UNAIDS 2030 target in Nigeria. Saudi Pharm J 2021; 29:815-819. [PMID: 34408543 PMCID: PMC8360771 DOI: 10.1016/j.jsps.2021.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Accepted: 06/09/2021] [Indexed: 11/18/2022] Open
Abstract
The approval of the novel long-acting HIV injection; Cabenuva®- Cabotegravir and Rilpivirine injectable formulation) and the recent call by the World Health Organization for promoting community-based ART management, underscore the remarkable progress towards meeting the Joint United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets by 2030. As the availability of antiretroviral therapy (ART) for the treatment of HIV/AIDS has increased in resource-limited settings, there has been a move to develop and implement alternative treatment delivery models such as Differentiated Service Delivery (DSD) in high prevalence countries to meet the global targets for HIV treatment while maintaining the quality of care. However, there is limited data on the involvement of community pharmacies in the delivery of ART within the community. Although, in western countries, several studies have documented the different roles community pharmacists can play in the management of HIV/AIDS. Community pharmacists are the most accessible and first points of health care for most clients. They are trusted, highly trained health care professionals. They should be incorporated and allowed to administer the Cabenuva® injection if the battle against the HIV pandemic is to be totally won. In this paper, we, therefore, aim to explore how the community pharmacist can be positioned in HIV service delivery regarding the administration of the Novel long-acting Cabenuva® injection formulation. It is therefore recommended that the Nigerian government embrace community pharmacy-led drug administration initiatives and embark on accredited training programmes for the profession in line with drug administration services. The government should also put in place necessary funding mechanisms for community pharmacists for the extra workload placed on them in administering injection drug formulation in their respective pharmacies.
Collapse
|
2
|
Were DK, Musau A, Atkins K, Shrestha P, Reed J, Curran K, Mohan D. Health system adaptations and considerations to facilitate optimal oral pre-exposure prophylaxis scale-up in sub-Saharan Africa. Lancet HIV 2021; 8:e511-e520. [PMID: 34265282 DOI: 10.1016/s2352-3018(21)00129-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Revised: 06/06/2021] [Accepted: 06/08/2021] [Indexed: 12/26/2022]
Abstract
Following WHO's 2015 recommendation, countries in sub-Saharan Africa have progressively scaled up oral pre-exposure prophylaxis (PrEP) as part of combination HIV prevention. PrEP has potential to significantly reduce new HIV infections in sub-Saharan Africa if it is widely available, accessible, and effectively used. Initial scale-up efforts have generated progress, drawing lessons from existing HIV interventions, such as antiretroviral therapy and biomedical prevention. However, beset by unprepared health systems, scale-up has been slow, resulting in suboptimal coverage among priority groups at higher risk of HIV acqusition. Using the WHO health system building blocks framework, this Review synthesises literature on essential considerations for PrEP scale-up in sub-Saharan Africa, highlighting the importance of health system adaptability and responsiveness.
Collapse
Affiliation(s)
| | | | - Kaitlyn Atkins
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Prakriti Shrestha
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | | | | | - Diwakar Mohan
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| |
Collapse
|
3
|
The only way is up: priorities for implementing long-acting antiretrovirals for HIV prevention and treatment. Curr Opin HIV AIDS 2021; 15:73-80. [PMID: 31688333 PMCID: PMC6903331 DOI: 10.1097/coh.0000000000000601] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Purpose of review Long-acting HIV treatment and prevention (LAHTP) can address some of the achievement gaps of daily oral therapy to bring us closer to achieving Joint United Nations Programme on HIV/AIDS Fast-track goals. Implementing these new technologies presents individual-level, population-level, and health systems-level opportunities and challenges. Recent findings To optimize LAHTP implementation and impact, decision-makers should define and gather relevant data to inform their investment case within the existing health systems context. Programmatic observations from scale-up of antiretroviral therapy, oral preexposure prophylaxis, voluntary medical male circumcision, and family planning offer lessons as planning begins for implementation of LAHTP. Additional data intelligence should be derived from formative studies, pragmatic clinical trials, epidemiologic and economic modeling of LAHTP. Key implementation issues that need to be addressed include optimal communication strategies for demand creation; target setting; logistics and supply chain of commodities needed for LAHTP delivery; human resource planning; defining and operationalizing monitoring and evaluating metrics; integration into health systems. Summary Successful LAHTP implementation can bolster treatment and prevention coverage levels if implementation issues outlined above are proactively addressed in parallel with research and development so that health systems can more rapidly integrate new technologies as they gain regulatory approval.
Collapse
|
4
|
Carrasco MA, Atkins K, Young R, Rosen JG, Grieb SM, Wong VJ, Fleming PJ. The HIV Pandemic Prevention Efforts Can Inform the COVID-19 Pandemic Response in the United States. Am J Public Health 2021; 111:564-567. [PMID: 33689445 PMCID: PMC7958034 DOI: 10.2105/ajph.2021.306158] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/04/2021] [Indexed: 11/04/2022]
Affiliation(s)
- Maria A Carrasco
- Maria A. Carrasco is with the Office of Population and Reproductive Health at the United States Agency for International Development (USAID), Washington, DC. Kaitlyn Atkins, Ruth Young, and Joseph G. Rosen are with the Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD. Suzanne M. Grieb is with the Johns Hopkins School of Medicine, Center for Child and Community Health Research, Baltimore. Vincent J. Wong is with the Office of HIV/AIDS at USAID. Paul J. Fleming is with the Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor.Note. The views in this publication do not necessarily reflect the views of the USAID, the US President's Emergency Plan for AIDS Relief, or the US government
| | - Kaitlyn Atkins
- Maria A. Carrasco is with the Office of Population and Reproductive Health at the United States Agency for International Development (USAID), Washington, DC. Kaitlyn Atkins, Ruth Young, and Joseph G. Rosen are with the Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD. Suzanne M. Grieb is with the Johns Hopkins School of Medicine, Center for Child and Community Health Research, Baltimore. Vincent J. Wong is with the Office of HIV/AIDS at USAID. Paul J. Fleming is with the Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor.Note. The views in this publication do not necessarily reflect the views of the USAID, the US President's Emergency Plan for AIDS Relief, or the US government
| | - Ruth Young
- Maria A. Carrasco is with the Office of Population and Reproductive Health at the United States Agency for International Development (USAID), Washington, DC. Kaitlyn Atkins, Ruth Young, and Joseph G. Rosen are with the Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD. Suzanne M. Grieb is with the Johns Hopkins School of Medicine, Center for Child and Community Health Research, Baltimore. Vincent J. Wong is with the Office of HIV/AIDS at USAID. Paul J. Fleming is with the Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor.Note. The views in this publication do not necessarily reflect the views of the USAID, the US President's Emergency Plan for AIDS Relief, or the US government
| | - Joseph G Rosen
- Maria A. Carrasco is with the Office of Population and Reproductive Health at the United States Agency for International Development (USAID), Washington, DC. Kaitlyn Atkins, Ruth Young, and Joseph G. Rosen are with the Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD. Suzanne M. Grieb is with the Johns Hopkins School of Medicine, Center for Child and Community Health Research, Baltimore. Vincent J. Wong is with the Office of HIV/AIDS at USAID. Paul J. Fleming is with the Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor.Note. The views in this publication do not necessarily reflect the views of the USAID, the US President's Emergency Plan for AIDS Relief, or the US government
| | - Suzanne M Grieb
- Maria A. Carrasco is with the Office of Population and Reproductive Health at the United States Agency for International Development (USAID), Washington, DC. Kaitlyn Atkins, Ruth Young, and Joseph G. Rosen are with the Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD. Suzanne M. Grieb is with the Johns Hopkins School of Medicine, Center for Child and Community Health Research, Baltimore. Vincent J. Wong is with the Office of HIV/AIDS at USAID. Paul J. Fleming is with the Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor.Note. The views in this publication do not necessarily reflect the views of the USAID, the US President's Emergency Plan for AIDS Relief, or the US government
| | - Vincent J Wong
- Maria A. Carrasco is with the Office of Population and Reproductive Health at the United States Agency for International Development (USAID), Washington, DC. Kaitlyn Atkins, Ruth Young, and Joseph G. Rosen are with the Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD. Suzanne M. Grieb is with the Johns Hopkins School of Medicine, Center for Child and Community Health Research, Baltimore. Vincent J. Wong is with the Office of HIV/AIDS at USAID. Paul J. Fleming is with the Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor.Note. The views in this publication do not necessarily reflect the views of the USAID, the US President's Emergency Plan for AIDS Relief, or the US government
| | - Paul J Fleming
- Maria A. Carrasco is with the Office of Population and Reproductive Health at the United States Agency for International Development (USAID), Washington, DC. Kaitlyn Atkins, Ruth Young, and Joseph G. Rosen are with the Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD. Suzanne M. Grieb is with the Johns Hopkins School of Medicine, Center for Child and Community Health Research, Baltimore. Vincent J. Wong is with the Office of HIV/AIDS at USAID. Paul J. Fleming is with the Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor.Note. The views in this publication do not necessarily reflect the views of the USAID, the US President's Emergency Plan for AIDS Relief, or the US government
| |
Collapse
|
5
|
Comprehensive HIV risk reduction interventions for 2020 and beyond: product choices and effective service-delivery platforms for individual needs and population-level impact. Curr Opin HIV AIDS 2020; 14:423-432. [PMID: 31261158 DOI: 10.1097/coh.0000000000000567] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
PURPOSE OF REVIEW This review summarizes key HIV prevention strategies in the 2020 toolkit and discusses opportunities to maximize the public health impact of these prevention interventions at a population level. RECENT FINDINGS HIV prevention has relied on counseling, HIV testing, and condom distribution for the past three decades. Recent exciting work has provided evidence on effective HIV prevention interventions, including antiretroviral therapy for HIV prevention, expanding preexposure prophylaxis modalities, and voluntary medical male circumcision which all reduce individual-level HIV risk. Efficient service-delivery approaches are necessary to deliver these products at scale while addressing population-specific needs. These approaches include: making it easier to get individuals HIV tested and linked to prevention services; de-medicalization to increase access to prevention products; creating welcoming clinic service-delivery environments; and integrating HIV prevention products into existing clinical platforms to support ongoing care engagement. SUMMARY The 2020 HIV prevention toolkit includes powerful HIV prevention options, and product choice will be increasingly imperative. Meeting ambitious global HIV reduction targets in the next decade will require improved service-delivery platforms to get prevention choices to persons at risk while layering prevention coverage to achieve population-level impact.
Collapse
|
6
|
Djomand G, Bingham T, Benech I, Muthui M, Savva H, Alamo S, Manopaiboon C, Wheeler T, Mital S. Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016-September 2018. MMWR. MORBIDITY AND MORTALITY WEEKLY REPORT 2020; 69:212-215. [PMID: 32107367 PMCID: PMC7367074 DOI: 10.15585/mmwr.mm6908a3] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the largest bilateral funder of human immunodeficiency virus (HIV) prevention and control programs worldwide, currently supports implementation of preexposure prophylaxis (PrEP) to reduce HIV incidence among persons at substantial risk for infection, including female sex workers, men who have sex with men (MSM), and transgender women (hereafter referred to as key populations). Recent estimates suggest that 54% of all global new HIV infections in 2018 occurred among key populations and their sexual partners (1). In 2016, PEPFAR began tracking initiation of PrEP by key populations and other groups at high risk (2). The implementation and scale-up of PrEP programs across 35 PEPFAR-supported country or regional programs* was assessed by determining the number of programs reporting any new PrEP clients during each quarter from October 2016 to September 2018. As of September 2018, only 15 (43%) PEPFAR-supported country or regional programs had implemented PrEP programs; however, client volume increased by 3,351% over the assessment period in 15 country or regional programs. Scale-up of PrEP among general population clients (5,255%) was nearly three times that of key population clients (1,880%). Among key populations, the largest increase (3,518%) occurred among MSM. Factors that helped drive the success of these PrEP early adopter programs included initiation of national, regional, and multilateral stakeholder meetings; engagement of ministries of health and community advocates; revision of HIV treatment guidelines to include PrEP; training for HIV service providers; and establishment of drug procurement policies. These best practices can help facilitate PrEP implementation, particularly among key populations, in other country or regional programs to reduce global incidence of HIV infection.
Collapse
|
7
|
Zhang C, Qian HZ, Liu Y, Vermund SH. Voluntary medical male circumcision and HIV infection among men who have sex with men: Implications from a systematic review. SAGE Open Med 2019; 7:2050312119869110. [PMID: 31448119 PMCID: PMC6689924 DOI: 10.1177/2050312119869110] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2019] [Accepted: 07/21/2019] [Indexed: 01/05/2023] Open
Abstract
Background: With the rapidly-increased HIV epidemic among men who have sex with men worldwide, the effectiveness of voluntary medical male circumcision as the tool of HIV prevention still remains undetermined. Purpose: In the current study, we conducted a systematic review and meta-analysis to assess the association between voluntary medical male circumcision and HIV risk among men who have sex with men. Methods and Conclusion: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline, we conducted a comprehensive literature search through multiple databases. A total of 37 articles/abstracts were included in the analysis. We employed random-effects models and subgroup analyses based upon key study characteristics derived from empirical studies. A total of 117,293 men who have sex with men were included in the meta-analysis, and no randomized control trials have been identified. The odds of being HIV positive were 7% lower among men who have sex with men who were circumcised than among men who have sex with men who were uncircumcised (adjusted odds ratio, 0.93; 95% confidence interval, 0.88–0.99). The evidence for the potential protective effect of voluntary medical male circumcision was stronger among men who have sex with men in Asia and Africa (adjusted odds ratio, 0.62; 95% confidence interval, 0.53–0.73). Our meta-analyses may suggest a protective effect of voluntary medical male circumcision against HIV infection among men who have sex with men, especially in settings like Asia/Africa.
Collapse
Affiliation(s)
- Chen Zhang
- School of Nursing, University of Rochester Medical Center, Rochester, NY, USA
| | - Han-Zhu Qian
- Yale School of Public Health, Yale University, New Haven, CT, USA
| | - Yu Liu
- Division of Epidemiology, Department of Public Health Science, University of Rochester Medical Center, Rochester, NY, USA
| | - Sten H Vermund
- Yale School of Public Health, Yale University, New Haven, CT, USA
| |
Collapse
|
8
|
Pyra MN, Haberer JE, Hasen N, Reed J, Mugo NR, Baeten JM. Global implementation of PrEP for HIV prevention: setting expectations for impact. J Int AIDS Soc 2019; 22:e25370. [PMID: 31456348 PMCID: PMC6712462 DOI: 10.1002/jia2.25370] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2019] [Accepted: 07/09/2019] [Indexed: 12/23/2022] Open
Abstract
INTRODUCTION Questions remain whether HIV pre-exposure prophylaxis (PrEP) can be translated into a successful public health intervention, leading to a decrease in population-level HIV incidence. We use examples from HIV treatment and contraceptives to discuss expectations for PrEP uptake, adherence, and persistence and their combined impact on the epidemic. DISCUSSION Targets for PrEP uptake must be based on the local HIV epidemic and will depend on appropriate estimates of the key populations at risk for HIV. However, there is evidence that targets, once established, can successfully be met and that uptake may increase with awareness. Messaging around adherence should include that daily adherence is the goal (except for those MSM for whom event-driven dosing is a good fit), but perfect adherence should not be a barrier. Ideally, clients persist on PrEP for as long as they are at risk for HIV. While PrEP will be most effective when coverage is focused on high-risk populations, normalizing rather than stigmatizing PrEP will be highly beneficial. CONCLUSIONS While many challenges to PrEP implementation exist, we focused on the three key steps of uptake, adherence and persistence as measurable processes that can lead to improved coverage and decreased HIV incidence.
Collapse
Affiliation(s)
- Maria N Pyra
- Department of Global HealthUniversity of WashingtonSeattleWAUSA
- Department of EpidemiologyUniversity of WashingtonSeattleWAUSA
| | - Jessica E Haberer
- Massachusetts General Hospital Global HealthBostonMAUSA
- Department of MedicineHarvard Medical SchoolBostonMAUSA
| | | | | | - Nelly R Mugo
- Department of Global HealthUniversity of WashingtonSeattleWAUSA
- Kenya Medical Research Institute (KEMRI)NairobiKenya
| | - Jared M Baeten
- Department of Global HealthUniversity of WashingtonSeattleWAUSA
- Department of EpidemiologyUniversity of WashingtonSeattleWAUSA
- Department of MedicineUniversity of WashingtonSeattleWAUSA
| |
Collapse
|
9
|
Zhang C, Penson DF, Qian HZ, Webb GF, Lou J, Shepherd BE, Liu Y, Vermund SH. Modeling economic and epidemiological impact of voluntary medical male circumcision among men who have sex with men in Beijing, China. Int J STD AIDS 2019; 30:630-638. [PMID: 30890118 PMCID: PMC6666307 DOI: 10.1177/0956462419831859] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Voluntary medical male circumcision (VMMC) among men who have sex with men (MSM) may protect against HIV acquisition. We conducted a series of analyses to assess if expanded VMMC might reduce HIV incidence among MSM effectively and economically. We used a deterministic compartmental model to project new HIV cases (2016-2026) under annual VMMC coverage rates (λ) ranging from 0.0001 to 0.15. The 'number needed to avert' (NNA) is defined as the cumulative number of VMMCs conducted up to that year divided by the cumulative number of HIV cases averted in that specific year. Compared with the baseline circumcision coverage rate, we projected that new HIV cases would be reduced with increasing coverage. By 2026 (last year simulated), the model generated the lowest ratio (11.10) when the annual circumcision rate was the most optimistic (λ = 0.15). The breakeven point was observed at the year of 2019 with the annual VMMC coverage rate of 0.001. The total cost saved by averting HIV cases would range from 2.5 to 811 million US dollars by the end of 2026 with different hypothetical coverage rates. Our model suggests that acceleration in VMMC implementation among MSM could help stem the HIV/AIDS epidemic.
Collapse
Affiliation(s)
- Chen Zhang
- School of Nursing, University of Rochester Medical Center, Rochester, New York, USA
| | - David F. Penson
- Departments of Urologic Surgery, Vanderbilt University, Nashville, Tennessee, USA
| | - Han-zhu Qian
- School of Public Health, Yale University, New Haven, Connecticut, USA
| | - Glenn F. Webb
- Department of Mathematics, Vanderbilt University School of Arts and Sciences, Nashville, Tennessee, USA
| | - Jie Lou
- Department of Mathematics, Shanghai University, Shanghai, China
| | - Brian E. Shepherd
- Department of Biostatistics, Vanderbilt University, Nashville, Tennessee, USA
| | - Yu Liu
- Department of Public Health Science, University of Rochester Medical Center, Rochester, New York, USA
| | - Sten H. Vermund
- School of Public Health, Yale University, New Haven, Connecticut, USA
| |
Collapse
|
10
|
Strategies for engaging men in HIV services. Lancet HIV 2019; 6:e191-e200. [PMID: 30777726 DOI: 10.1016/s2352-3018(19)30032-3] [Citation(s) in RCA: 74] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2018] [Revised: 12/20/2018] [Accepted: 12/20/2018] [Indexed: 12/14/2022]
Abstract
The importance of men in the global HIV response is increasingly recognised. In most settings, men are less engaged in HIV services and have worse health outcomes than women. The multiple gender, social, economic, political, and institutional factors behind these patterns are well documented. More recently, researchers have been reporting evidence on strategies aimed at improving the engagement of men in HIV services. Several promising approaches exist, including community-based outreach programmes, gender-transformative interventions to shift gender norms and practices, and the development of more responsive, male-friendly health services. Challenges remain, however, in terms of cost and sustainability, intersecting inequalities like race and class, and the difficulty of changing community-level gender norms. Future research should focus on developing theory-informed interventions and evaluations, on improving the understanding of specific subpopulations of men, and on broadening the evidence base beyond the few countries that produce most research in this field.
Collapse
|
11
|
Gomez A, Loar R, England Kramer A. The impact of market segmentation and social marketing on uptake of preventive programmes: the example of voluntary medical male circumcision. A literature review. Gates Open Res 2018; 2:68. [PMID: 31131368 PMCID: PMC6480503 DOI: 10.12688/gatesopenres.12888.1] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/29/2018] [Indexed: 11/20/2022] Open
Abstract
Background: The business world has long recognized the power of defining discrete audiences within a target population. However, market segmentation's full potential has not been applied to the public health context. While some broad elements of market segmentation (e.g., age, geography) are considered, a nuanced look at behavioural and psychographic segmentation, which could greatly enhance the possibility of lasting behaviour change, is often missing. Segmentation, and the associated mindset which acknowledges the multi-dimensional differences between people, allows service providers, implementers, policymakers, and government officials to target initiatives and lead to a greater likelihood of lasting behavioural change. This paper investigates what segmentation is, how it has been applied to voluntary medical male circumcision (VMMC), how it can be applied in development, and the challenges in both measuring and adopting segmentation as part of program design. Methods: We performed a detailed search of peer-reviewed literature using PubMed, ProQuest, ScienceDirect, Google Scholar, and the abstract directories of the International AIDS Society (IAS) published between January 2015 and September 2018. We also accessed articles from business databases such as the Harvard Business Review. Results: Results from a VMMC-focused intervention that successfully designed and delivered segmentation-based programs in two countries demonstrated that it is possible to adapt private sector approaches. However, within the sector of global development that is most familiar with segmentation, these efforts rarely go beyond basic demographic segments. Conclusions: Existing published material tends not to measure the impact of segmentation itself, but the impact of the intervention to which segmentation was applied, which makes it challenging for the development sector to invest in the approach without evidence that it works. Nonetheless, the experiences of segmentation and demand creation for VMMC do highlight the opportunity for better integrating this approach in HIV prevention and in global development and measurement initiatives.
Collapse
Affiliation(s)
| | - Rebecca Loar
- Independent Consultant, Independent Consultant, Austin, Texas, USA
| | | |
Collapse
|